Twin Tree Management
MRNA icon

Twin Tree Management’s Moderna MRNA Stock Holding History

Twin Tree Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-125,203
Closed -$6.36M – 1604
2026
Q1 		$6.36M Buy
125,203
+57,026
+84% +$2.66M 0.13% 166
2025
Q4 		$2.01M Buy
68,177
+63,131
+1,251% +$1.72M 0.02% 826
2025
Q3 		$130K Sell
5,046
-72,771
-94% -$2.03M ﹤0.01% 1363
2025
Q2 		$2.15M Sell
77,817
-288,657
-79% -$7.6M ﹤0.01% 1240
2025
Q1 		$10.4M Buy
+366,474
New +$13M 0.02% 652
2024
Q4 		– Sell
-104,797
Closed -$5.01M – 1800
2024
Q3 		$7M Buy
104,797
+25,244
+32% +$2.32M 0.01% 792
2024
Q2 		$9.45M Buy
79,553
+62,496
+366% +$7.91M 0.02% 588
2024
Q1 		$1.82M Sell
17,057
-239,065
-93% -$24.1M ﹤0.01% 999
2023
Q4 		$25.5M Sell
256,122
-62,235
-20% -$5.23M 0.05% 392
2023
Q3 		$32.9M Buy
318,357
+22,461
+8% +$2.51M 0.07% 246
2023
Q2 		$36M Buy
295,896
+289,026
+4,207% +$38.6M 0.06% 273
2023
Q1 		$1.06M Sell
6,870
-27,050
-80% -$4.46M ﹤0.01% 997
2022
Q4 		$6.09M Sell
33,920
-159,803
-82% -$26.1M 0.01% 692
2022
Q3 		$22.9M Sell
193,723
-129,566
-40% -$19.7M 0.04% 348
2022
Q2 		$46.2M Buy
323,289
+248,772
+334% +$35.6M 0.07% 205
2022
Q1 		$12.8M Sell
74,517
-112,688
-60% -$19M 0.02% 626
2021
Q4 		$47.5M Buy
+187,205
New +$54.7M 0.1% 173
2021
Q2 		– Sell
-155
Closed -$27.7K – 1529
2021
Q1 		$20K Buy
+155
New +$22.5K ﹤0.01% 1239
2020
Q3 		– Sell
-18,872
Closed -$1.32M – 1479
2020
Q2 		$1.21M Sell
18,872
-78,065
-81% -$4.28M ﹤0.01% 1005
2020
Q1 		$2.9M Buy
+96,937
New +$2.23M 0.01% 626

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Twin Tree Management's MRNA Position: Q2 2026 in Review

Twin Tree Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 125,203 shares — an estimated $6.36M sold.

Twin Tree Management first reported a position in MRNA in Q1 2020 and held it in 20 quarters. The position peaked at $47.5M in Q4 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Twin Tree Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Twin Tree Management sold 125,203 Moderna shares in Q2 2026, an estimated $6.36M.
  • Twin Tree Management first reported a position in Moderna in Q1 2020 and held it in 20 quarters.
  • Twin Tree Management's Moderna position peaked at $47.5M in Q4 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Twin Tree Management's 13F filing for Q2 2026, filed 12 Aug 2026.